Joint Formulary & PAD

Cyclopentolate hydrochloride - Uveitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Eye drops
  • Eye drops (preservative free
  • unit dose)
Associated Icons :
SPC
Restrictions / Comments :
Important

eye drops 0.5%, 1%

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Cyclopentolate hydrochloride
Indication :
Uveitis
Group Name :
Keywords :
eye drops, minims
Brand Names Include :
Mydrilate, Minims
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Cyclopentolate hydrochloride is used to treat.

Committee Recommendations (1)

The Prescribing Clinical Network recommends the use of cyclopentolate eye drops (0.5% & 1%) for the treatment licensed hospital indications ( including Iritis and Uveitis)

Cyclopentolate eye drops will be considered to be RED on the traffic light system.

New patients should be initiated on cyclopentolate eye drops by their consultant ophthalmologist.